Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATHLOS: BGF MDI vs BFF MDI vs placebo on exercise parameters in COPD
CTR20242591Phase 3Active
- Sponsor
- AstraZeneca
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Breztri Aerosphere, budesonide + formoterol, Placebo-COD Research Private Ltd in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Nov 2024; status: active.
02
Drugs
Breztri Aerospherebudesonide + formoterolPlacebo-COD Research Private Ltd
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20242591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242591.